Lataa...

Study partners should be required in preclinical Alzheimer’s disease trials

BACKGROUND: In an effort to intervene earlier in Alzheimer’s disease (AD), clinical trials are testing promising candidate therapies in preclinical disease. Preclinical AD trial participants are cognitively normal, functionally independent, and autonomous decision-makers. Yet, like AD dementia trial...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Res Ther
Päätekijät: Grill, Joshua D., Karlawish, Jason
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2017
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5719524/
https://ncbi.nlm.nih.gov/pubmed/29212555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0327-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!